Compugen Ltd. to Review Third Quarter 2008 Results on Thursday, November 13, 2008.

Conference Call to Be Held at 11:00 AM EST 

TEL AVIV, Israel -- Compugen Ltd. (NASDAQ:CGEN) today announced that the Company plans to host a live conference call and webcast at 11:00 AM EST on Thursday, November 13, 2008 to review third quarter 2008 results. The quarterly results will be released prior to the conference call.

To access the conference call, please dial 1-888-281-1167 from the US or [phone] internationally. The call will also be available via live webcast through Compugen's Website, located at www.cgen.com.

A replay of the conference call will be available approximately two hours after the completion of the live conference call. To access the replay, please dial 1-888-295-2634 from the US or [phone] internationally. The replay will be available until 12 noon EST on November 16, 2008.

About Compugen

Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen's discovery efforts are based on in-silico (by computer) prediction and selection utilizing a growing number of field focused proprietary discovery platforms accurately modeling biological processes at the molecular level. The resulting product candidates are then validated through in vitro and in vivo experimental studies and out-licensed for further development and commercialization under various forms of revenue sharing agreements. Compugen's current collaborations include Biosite, Medarex, Inc., Merck & Co., Inc., Ortho-Clinical Diagnostics (a Johnson & Johnson company), Roche, Siemens Healthcare Diagnostics, Inc., and Teva Pharmaceutical Industries.

In 2002, Compugen established an affiliate, Evogene Ltd. www.evogene.com (TASE:EVGN.TA), to utilize certain of the Company's in-silico predictive discovery capabilities in agricultural biotechnology. For additional information, please visit Compugen's corporate Web site at www.cgen.com.